资讯

Dyne Therapeutics - Emergence As A Superior DM1 / DMD Player Warrants Rating Upgrade
I am upgrading Dyne Therapeutics stock to a 'Buy' rating due to promising late-stage DM1 and DMD drug candidates and ...